
Shatha AbuHammad
@shathaabuhammad
Scientist @danafarber @harvardmed 🧬🔬🧪
ID: 1117354080
24-01-2013 17:54:22
33 Tweet
54 Followers
198 Following




🧵Grateful to share our work JAMA Oncology Daniel Heng outlining the rapid pace of change in advanced #kidneycancer #renalcellcarcinoma. A brief tweetorial. Combination approaches, IOIO and IO/VEGF have changed the paradigm for patients...1/4 jamanetwork.com/journals/jamao…


From genotype to phenotype: genetics of mammalian long non-coding RNAs in vivo go.nature.com/3nZtDns #Review by Daniel Andergassen and @Noncodarnia TU München CU Boulder 🦬

More fireworks after 6 pm at #AACR23: #CICR townhall with 3 awesome talks about molecular glue degraders. Michael Rapé (Rapé Lab), Riccardo Sabatini (Orionis Biosciences) & Mary Matyskiela (neomorphinc). Chaired by Ben Ebert (Dana-Farber Chemical Biology Program). Glueing everybody to their seats. AACR #TPD


Front line role of our leading cancer researchers at #AACR23 in tackling one of cancers holy grails - targeting the RAS oncogene Ben Solomon #JayeshDesai abstractsonline.com/pp8/#!/10828/s…



A kill switch from The Amit Choudhary Lab uses molecular glue to “shred” Cas9 and remove it from cells to control CRISPR editing, as described in a bioRxiv, I. Emilie Steinmark reports. Broad Institute ErikSontheimerLab Karen Maxwell Avery August bit.ly/3n6WkBf




How can you uncover novel biological mechanisms beginning with observations from human genetics? Read this: Large-scale variant-to-function mapping in primary hematopoietic stem and progenitor cells from Xavier Lab sciencedirect.com/science/articl…



🎯Targeted protein degradation as a therapeutic strategy: the focus of the 39th #BarcelonaBioMed Conference. 🗣The Fundación BBVA & #IRBBarcelona are bringing together in #Barcelona more than 150 scientists from 🌏all over the world to discuss the latest advances in this



